Scientific advisors & partners update

AI SummaryClose X

IXICO plc has expanded its Scientific Advisory Board with the addition of leading experts in Alzheimer's and Parkinson's disease, Professor Jeffrey Cummings, Professor Charles DeCarli, and Professor Stéphane Lehéricy, to enhance its neuroscience imaging and biomarker analytics capabilities. The company has also initiated two new scientific R&D initiatives in Parkinson's disease, including a research collaboration with the Paris Brain Institute to evaluate novel neuromelanin-sensitive MRI approaches and participation in The Michael J. Fox Foundation's MRI Advisory Committee to advance quantitative MRI biomarkers for Parkinson's research. These developments aim to strengthen IXICO's position in the central nervous system drug development sector.

Disclaimer*

Companies

Ixico (IXI)
UK 100

Latest directors dealings